Compare CEPL & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CEPL | FOCL |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 203.7M |
| IPO Year | 2000 | 1998 |
| Metric | CEPL | FOCL |
|---|---|---|
| Price | $6.40 | $4.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 484.0K | 201.2K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,004,000.00 | $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.89 | 1.63 |
| 52 Week Low | $5.84 | $4.08 |
| 52 Week High | $12.32 | $6.40 |
| Indicator | CEPL | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 36.61 | 29.23 |
| Support Level | N/A | N/A |
| Resistance Level | $8.72 | $5.64 |
| Average True Range (ATR) | 0.85 | 0.30 |
| MACD | -0.07 | -0.18 |
| Stochastic Oscillator | 9.34 | 8.07 |
Capstone Energy+ Inc provides behind-the-meter clean energy solutions for industrial and commercial operations, as well as solutions for artificial intelligence (AI) and data center applications. It develops and manufactures oil-free, microturbine-based power generation systems designed to operate on a range of gaseous fuels.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.